Log In
Print
BCIQ
Print
Print this Print this
 

TAS-106

  Manage Alerts
Collapse Summary General Information
Company Taiho Pharmaceutical Co. Ltd.
DescriptionRNA polymerase inhibitor and antimetabolite
Molecular Target
Mechanism of ActionVaccine; RNA polymerase inhibitor
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase I/II
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today